Human Glioma Nude Mouse Xenograft Model in situ

Backgrounds: Surgery and chemotherapy are difficult because of the specific location of the glioma. The establishment of a suitable in situ model of glioma is the premise of the treatment of glioma. 8 week-old female BALB/c nude mice were chose to establish the glioma model. Methods: For the orthotopic glioma mice model, 1 × 105cells/5 μL U87-MG-Luc or U87-MG cells which were trypsinized and resuspended in sterile PBS were slowly injected into the right corpus striatum (1.8 mm lateral, 0.6 mm anterior to the bregma and 3.0 mm in depth) by a stereotactic fixation device using a mouse adaptor. Results: The othotopic U87 glioma mice model identified by imaging on IVIS Spectrum and magnetic resonance imaging after 2 weeks from surgery. H&E-stained tumor sections in brain of the mice model were also observed. Conclusions: After identification, the glioma mouse xenograft in situ model obtained could be used in the evaluation system of therapeutic drugs or methods.

[1]  Jian Wang,et al.  Factors Prognostic for Brain Metastases from Colorectal Cancer: A Single-Center Experience in China , 2021, Cancer management and research.

[2]  T. Higashi,et al.  Establishment of an In Vivo Xenograft Mouse Model of a Subcutaneous Submillimeter HT-29 Tumor Formed from a Single Spheroid Transplanted Using Radiation-Crosslinked Gelatin Hydrogel Microwell , 2021, Applied Sciences.

[3]  B. Mania-Farnell,et al.  Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine , 2021, Cancers.

[4]  M. Hadamitzky,et al.  Rodent Models to Analyze the Glioma Microenvironment , 2021, ASN neuro.

[5]  Z. Qiu,et al.  392P Clinical data from the real world: Efficacy analysis of ceritinib (450mg) in ALK-positive non-small cell lung cancer patients with brain metastases in China , 2020 .

[6]  Shijian Liu,et al.  Characteristics and trends of childhood cancer in Pudong, China, 2002–2015 , 2020, BMC Public Health.

[7]  T. Hara.  Abstract 3777: Exploring phenotypic mosaicism in a mouse model of glioma towards understanding intratumoral heterogeneity , 2019, Tumor Biology.

[8]  P. Lowenstein,et al.  TMOD-02. CHARACTERIZATION OF THE TUMOR IMMUNE MICROENVIRONMENT IN A PEDIATRIC HIGH GRADE GLIOMA MOUSE MODEL HARBORING THE H3.3-G34R MUTATION , 2019, Neuro-Oncology.

[9]  C. Fuller,et al.  TMOD-17. DEVELOPMENT AND CHARACTERIZATION OF DIFFUSE INTRINSIC PONTINE GLIOMA MOUSE MODELS GENERATED BY BRAINSTEM IN UTERO ELECTROPORATION , 2018, Neuro-Oncology.

[10]  I. Alafuzoff,et al.  Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype. , 2017, Cancer research.

[11]  C. Miller,et al.  Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models , 2017, Brain pathology.

[12]  N. Gu,et al.  Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma , 2016, International journal of nanomedicine.

[13]  V. Yang,et al.  Magnetic Targeting of Novel Heparinized Iron Oxide Nanoparticles Evaluated in a 9L-glioma Mouse Model , 2014, Pharmaceutical Research.

[14]  M. Samii,et al.  Morphometrical Characterization of Two Glioma Models in the Brain of Immunocompetent and Immunodeficient Rats , 1999, Journal of Neuro-Oncology.

[15]  Jingqin,et al.  Quantitative MRI assessment of glioma response to bevacizumab in a mouse model , 2017 .